Related Experiment Video
Updated: Feb 26, 2026

A RAPID Method for Blood Processing to Increase the Yield of Plasma Peptide Levels in Human Blood
Published on: April 28, 2016
Plasma Amino-Terminal Propeptide of C-Type Natriuretic Peptide Concentration in Normal-Weight and Obese Children
Seda Topçu1, Bayram Özhan2, Afra Alkan3
1Ankara University Faculty of Medicine, Department of Pediatrics, Division of Social Pediatrics, Ankara, Turkey.
Insights
Amino-terminal propeptide of C-type natriuretic peptide (NT-proCNP) is linked to growth velocity in children. However, this study found NT-proCNP is not a reliable biomarker for childhood obesity in the Turkish population.
Area of Science:
- Pediatric Endocrinology
- Biomarkers
- Childhood Growth and Obesity
Background:
- C-type natriuretic peptide (CNP) is an emerging growth marker in children.
- Previous studies suggest plasma CNP levels may be reduced in obese adolescents, indicating potential as a biomarker.
- The role of CNP in childhood obesity requires further investigation.
Purpose of the Study:
- To investigate the relationship between amino-terminal propeptide of C-type natriuretic peptide (NT-proCNP) concentration and height velocity in children.
- To test the hypothesis that CNP is a potential biomarker in childhood obesity within a Turkish population.
Main Methods:
- A cohort of 317 children (ages 0-18) and their parents provided consent.
- Physical examinations and anthropometric measurements, including BMI, were conducted.
- Plasma NT-proCNP concentration was measured using enzyme-linked immunosorbent assay (ELISA) from routine blood samples.
Main Results:
- Plasma NT-proCNP concentration correlated negatively with age, weight, and height, confirming its association with growth velocity.
- Gender did not significantly affect age-dependent plasma NT-proCNP concentration before puberty.
- Contrary to prior reports, overweight/obese children in this Turkish cohort did not show significantly lower plasma NT-proCNP levels compared to normal-weight children.
Conclusions:
- The study did not find plasma NT-proCNP to be a significantly lower in overweight/obese children compared to normal-weight children in the analyzed Turkish population.
- It is premature to conclude that CNP is a reliable biomarker for childhood obesity.
- Further research is needed to clarify the role of CNP in childhood obesity.
Objective:
In studies on the relationship between amino-terminal propeptide of C-type natriuretic peptide (NT-proCNP) concentration and height velocity in children, CNP has been implicated as an emerging new growth marker during childhood. It has been reported that besides its well-studied role in growth, plasma CNP levels are reduced in overweight and/or obese adolescents, suggesting CNP as a potential biomarker in childhood obesity. The primary goal of this study was to test this hypothesis in a Turkish population.
Methods:
Consent was taken from 317 children [ages 0-18 (158 girls, 159 boys)] and their parents. All subjects were physically examined; anthropometric measurements were obtained. Body mass index was calculated. During routine blood work, 1 mL extra blood was taken. Plasma NT-proCNP concentration was measured by enzyme-linked immunosorbent assay.
Results:
Results confirmed the previously described relationship between plasma NT-proCNP concentration and growth velocity. Plasma NT-proCNP concentration showed a negative correlation with age, weight, and height in children. Gender was not a factor that alters the age-dependent plasma NT-proCNP concentration until puberty.
Conclusion:
Unlike previous reports, plasma NT-proCNP concentration of overweight/obese children was not significantly lower than that of children with normal weight in age groups analyzed in a Turkish population. Thus, it is too early to conclude that CNP is a potential biomarker in childhood obesity. Further studies are necessary to address this question.
More Related Videos
Related Concept Videos
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Pharmacokinetics in Pediatric Patients: Drug Distribution
Drug Dosing: Obese Patients
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:
Hormonal Regulation of Blood Pressure
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction...
Regulation of Food Intake

